
Duo Oncology
Recorded December 04, 2025
Duo Oncology is a next-generation biotech company creating a nanomedicine platform that replaces chemotherapy for hard-to-treat cancers

Duo Oncology is a next-generation biotech company creating a nanomedicine platform that replaces chemotherapy for hard-to-treat cancers

Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain

XSponse is a comprehensive AI-powered security ecosystem that unifies detection, alerting, and mass notification into one integrated platform.

Scout Discoveries is a vertically integrated exploration company that is ready to meet the demand for domestically sourced critical minerals

Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA

BrainScope has a pipeline that spans stroke, Alzheimer’s, concussion, and beyond, and is uniquely positioned in a $21B+ global market

Innova Vascular is producing FDA-cleared medical devices that remove dangerous blood clots more effectively and safely than existing options.

Hummingbird Tympanostomy Tube System enables ear tube placement for children at a doctor’s office in just minutes, dramatically reducing healthcare costs

General Oncology, Inc., is advancing late-stage oncology and ophthalmology programs with human proof-of-concept data and a defined path to liquidity.

CloudCover is an AI-powered cloud security platform that can detect, measure, and prevent risk at the data packet level.

Araceli’s ultra-high-throughput imaging platform is poised to become the backbone of AI-driven drug discovery and therapeutics.

5E Advanced Materials (NASDAQ: FEAM) produces boron to support national security, energy transition, and agricultural resilience in the U.S.